Morgan Stanley’s Zentalis Pharmaceuticals ZNTL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$819K Sell
350,207
-453,447
-56% -$1.17M ﹤0.01% 5247
2025
Q4
$1.08M Sell
803,654
-604,175
-43% -$879K ﹤0.01% 5144
2025
Q3
$2.13M Buy
1,407,829
+310,178
+28% +$465K ﹤0.01% 4736
2025
Q2
$1.27M Buy
1,097,651
+3,693
+0.3% +$4.87K ﹤0.01% 4985
2025
Q1
$1.74M Sell
1,093,958
-619,230
-36% -$1.34M ﹤0.01% 4693
2024
Q4
$5.19M Buy
1,713,188
+101,621
+6% +$333K ﹤0.01% 3963
2024
Q3
$5.93M Sell
1,611,567
-339,155
-17% -$1.23M ﹤0.01% 3840
2024
Q2
$7.98M Buy
1,950,722
+913,313
+88% +$10.2M ﹤0.01% 3492
2024
Q1
$16.3M Sell
1,037,409
-181,557
-15% -$2.5M ﹤0.01% 2913
2023
Q4
$18.5M Buy
1,218,966
+673,346
+123% +$9.82M ﹤0.01% 3418
2023
Q3
$10.9M Buy
545,620
+42,745
+9% +$1.08M ﹤0.01% 3043
2023
Q2
$14.2M Buy
502,875
+231,611
+85% +$5.56M ﹤0.01% 2836
2023
Q1
$4.67M Buy
271,264
+137,805
+103% +$2.79M ﹤0.01% 3837
2022
Q4
$2.69M Buy
133,459
+36,065
+37% +$776K ﹤0.01% 4265
2022
Q3
$2.11M Sell
97,394
-248,345
-72% -$6.79M ﹤0.01% 4386
2022
Q2
$9.71M Buy
345,739
+167,894
+94% +$4.45M ﹤0.01% 3095
2022
Q1
$8.21M Buy
177,845
+147,701
+490% +$7.97M ﹤0.01% 3141
2021
Q4
$2.53M Sell
30,144
-18,087
-38% -$1.4M ﹤0.01% 4391
2021
Q3
$3.21M Sell
48,231
-20,251
-30% -$1.17M ﹤0.01% 4160
2021
Q2
$3.64M Buy
68,482
+15,413
+29% +$825K ﹤0.01% 4111
2021
Q1
$2.3M Sell
53,069
-47,851
-47% -$2.06M ﹤0.01% 4141
2020
Q4
$5.24M Buy
100,920
+93,346
+1,232% +$4.21M ﹤0.01% 3210
2020
Q3
$248K Sell
7,574
-2,551
-25% -$89.3K ﹤0.01% 4996
2020
Q2
$486K Buy
+10,125
New +$388K ﹤0.01% 4614

Other funds holding ZNTL